At the HealthLeaders Revenue Cycle Technology Mastermind forum this week in Savannah, RCM executives talked of how AI is giving them a new profile – and compelling them to work more closely with ...

To lead in the agentic era, executives must champion synthetic data as a foundation for innovation, while pairing it with ...

Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...

AI models are only as good as the data they're trained on. That data generally needs to be labeled, curated and organized ...

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug ...

Much of the evidence documenting the earliest use of psilocybin in mushrooms for medicinal purposes by the ancient Mayans and Aztecs was destroyed by Spanish missionaries in the 1500s. However, that ...

A conversation on rural health care—plus, news on the Kaiser Permanente worker strike and a look at Sandford Health's latest ...

Traditionally, nutrition professionals have relied on self-reported food logs, interviews, and recall surveys, methods prone ...

Founded by Duke Health innovator Dr. Mark Sendak, the company offers a marketplace of validated AI tools and will work with ...

From prior authorization hurdles to quantity caps, insurance restrictions on antiemetics are common and inconsistent across plans, drugs, and states, new data show.

PSC, a chronic liver disease characterized by inflammation and scarring of the bile ducts, is frequently seen alongside IBD, ...